FREE SHIPPING ON ORDERS OVER $150

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

$25.30

Quantity
- +
Description

Author Contributions All authors contributed to the conception and design of the study

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

[DOI] [PMC free article] [PubMed] [Google Scholar] 102.Darpo B, Philip S, MacConell L, Cirincione B, Mitchell M, Han J, Huang W, Malloy J, Schulteis C, Shen L, Porter L

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

Vitam Horm

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

Diabetes Care (2014) 37:216876

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

Contact Us: Persistence Market Research G04 Golden Mile House, Clayponds Lane Brentford, London, TW8 0GU UK USA Phone: +1 646-878-6329 UK Phone: +44 203-837-5656 Email: [email protected] Web: About Persistence Market Research: At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth

first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes Discontinuing GLP-1s Before or Early

You may also like

recommand products